Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Rev. méd. Chile ; 140(11): 1464-1475, nov. 2012. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-674015

RESUMO

During the past decade the role of folate and vitamin B12 in human nutrition have been under constant re-examination. Basic knowledge on the metabolism and interactions between these essential nutrients has expanded and multiple complexities have been unraveled. These micronutrients have shared functions and intertwined metabolic pathways that define the size of the "methyl donor" pool utilized in multiple metabolic pathways; these include DNA methylation and synthesis of nucleic acids. In Chile, folate deficiency is virtually nonexistent, while vitamin B12 deficiency affects approximately 8.5-51% depending on the cut-off value used to define deficiency. Folate is found naturally mainly in vegetables or added as folic acid to staple foods. Vitamin B12 in its natural form is present only in foods of animal origin, which is why deficit is more common among strict vegetarians and populations with a low intake of animal foods. Poorfolate status in vulnerable women of childbearing age increases the risk of neural tube birth defects, so the critical time for the contribution of folic acid is several months before conception since neural tube closure occurs during the first weeks of life. The absorption of vitamin B12 from food is lower in older adults, who are considered to have higher risk of gastric mucosa atrophy, altered production of intrinsic factor and acid secretion. Deficiency of these vitamins is associated with hematological disorders. Vitamin B12 deficiency can also induce clinical and sub-clinical neurological and of other disorders. The purpose of this review is to provide an update on recent advances in the basic and applied knowledge of these vitamins relative to human health.


Assuntos
Humanos , Ácido Fólico , Deficiência de Ácido Fólico , Dieta , Deficiência de Ácido Fólico/diagnóstico , Deficiência de Ácido Fólico/etiologia , Deficiência de Ácido Fólico/terapia , Ácido Fólico/administração & dosagem , Ácido Fólico/química , Ácido Fólico/metabolismo , Alimentos Fortificados , /diagnóstico , /etiologia , /terapia , /administração & dosagem , /química , /metabolismo
2.
São Paulo; s.n; 2009. 135 p. ilus, tab, graf.
Tese em Português | LILACS | ID: lil-566890

RESUMO

A suplementação com ácido fólico (AF) apresenta efeitos quimiopreventivos, porém, pode aumentar o risco de desenvolvimento e acelerar a progressão do câncer se ocorrer em doses elevadas ou após a ocorrência de lesões pré-neoplásicas (LPN). O AF é essencial na síntese de novo de purinas e timidalato e consequentemente na síntese, replicação e reparo do DNA, proliferação celular e apoptose. Assim, a deficiência pode implicar em danos ao DNA e erros na sua replicação e reparo, processos importantes na carcinogênese, onde as células apresentam taxas de replicação e divisão aceleradas, e é possível que a suplementação module estes processos. Além disso, como AF ocupa uma posição de destaque no metabolismo dos grupamentos metila pode exercer efeitos sobre a hipometilação global do DNA e o aumento da expressão de proto-oncogenes como o c-myc, fenômenos característicos da hepatocarcinogênese. Assim, objetivando-se avaliar os efeitos do AF na promoção da hepatocarcinogênese em ratos Wistar, desenvolveu-se o modelo do /"Hepatócito Resistente/" e administrou-se por entubação gástrica diariamente, durante 5 semanas, o AF (0,16; 0,32; ou 0,64 mg / 100 g de peso / dia) ou água (0,25 mL / 100 g de peso / dia). Então, avaliou-se as LPN hepáticas presentes visíveis à macroscopia e microscopia (GST-P), a proliferação celular (BrdU) e a apoptose (microscopia de fluorescência) no tecido hepático ao redor das LPN e nas LPN persistentes e em remodelação, a intensidade de danos ao DNA (/"Cometa/" alcalino), e o padrão de metilação global (Dot Blot) e a expressão do c-myc (RT-PCR) especificamente em LPN microdissecadas. Apesar de não ter alterado a incidência e multiplicidade das LPN, o tratamento com AF 0,32 mg / 100 g promoveu um aumento na porcentagem de lesões ≥ 1 mm e o com AF 0,64 mg / 100 g a diminuição na porcentagem dessa lesões com relação ao grupo água (p<0,05). De modo semelhante, observou-se na análise das LPN GST-P positivas que o AF 0,32 mg / 100 g promoveu aumento e...


Folic acid (FA) supplementation shows chemopreventive effects, however, it may increase the risk of development and accelerate cancer progression in case of high doses or after preneoplastic lesions (PNL) are established. FA is essential on de novo synthesis of purine and thymidalate and, consequently, on DNA synthesis, replication and repair, cell proliferation and apoptosis. Thus, its deficiency may cause DNA damage and replication and repair mistakes, important processes on carcinogenesis, where cells present high replication rates and accelerated division, and is possible that supplementation modulates these processes. Besides, as FA has a central role on methyl group metabolism, it may have effects on hepatocarcinogenesis peculiar events such as DNA global hypomethylation and on the increased expression of proto-oncogenes like c-myc. Objecting the evaluation of FA effects during hepatocarcinogenesis promotion in Wistar rats, the /"Resistant Hepatocyte/" model was developed and water (0.25 mL / 100 g BW / day) or FA (0.16; 0.32; or 0.64 mg / 100 g BW / day) were supplemented daily by gavage for 5 weeks. Then, hepatic PNL detected by macroscopy and microscopy (GST-P), cell proliferation (BrdU) and apoptosis (fluorescence microscopy) on surrounding tissue, persistent and remodeling PNL, DNA damage (alcaline Comet assay), DNA global methylation pattern (Dot Blot) and c-myc expression (RT-PCR) specifically in microdissected PNL were evaluated. Even though FA treatment was not able to change incidence and multiplicity of PNL, the treatment with 0.32 mg / 100 g of FA increased the percentage of lesions ≥ 1 mm whereas with 0.64 mg / 100 g of FA diminished the percentage of these lesions, compaired to the water group (p<0.05). Similarly, it could be observed in PNL positive GST-P analysis that FA 0.32 mg / 100 g enhanced and FA 0.64 mg / 100 g inhibited the carcinogenic process, although it was not possible to detect significant differences on number, size and…


Assuntos
Animais , Masculino , Ratos , Ácido Fólico/química , Ácido Fólico/toxicidade , Carcinoma Hepatocelular , Vitaminas na Dieta , Alimentos , Fenômenos Fisiológicos da Nutrição
3.
Indian J Biochem Biophys ; 2008 Dec; 45(6): 421-9
Artigo em Inglês | IMSEAR | ID: sea-27338

RESUMO

The solid state spectroscopy of charge transfer complexes of biomolecules such as fatty acids, tripalmitin, lysozyme. folic acid, beta-carotene, cytochrome c, valinomycin and gramicidin has been carried out. The absorption coefficient is related with electronic conductivity. A half-power beta density is found common among these macromolecular solids, indicating photon-induced polaron hopping or hopping of a charge carrier between two branches of a polariton. Band gap vs full width at half-maximum of the mid-IR peak also reveals a linear relation.


Assuntos
Citocromos c/química , Condutividade Elétrica , Enzimas/química , Ácidos Graxos/química , Ácido Fólico/química , Gramicidina/química , Muramidase/química , Compostos Orgânicos/química , Teoria Quântica , Análise Espectral/métodos , Triglicerídeos/química , Valinomicina/química , beta Caroteno/química
4.
PJMR-Pakistan Journal of Medical Research. 1986; 25 (4): 204-12
em Inglês | IMEMR | ID: emr-94963

RESUMO

The stability of folic acid in water at pH 7.5 was studied in the presence of other vitamins such as ascorbic acid, pyridoxine hydrochloride, riboflavin and thiamine hydrochloride. The two component mixtures contained 1:1 folic acid and another vitamin and concentration of each outs 0.002%. Sunlight, heat and oxygen have adverse effects on the stability of such preparations. The half and self lives of folic acid in the preparations were calculated


Assuntos
Ácido Fólico/química , Complexo Vitamínico B , Estabilidade de Medicamentos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA